Results 21 to 30 of about 591,365 (304)

The Effect of Type 2 Diabetes Mellitus on the Prognosis of Patients with Dilated Cardiomyopathy [PDF]

Zhongguo quanke yixue, 2023
Background Type 2 diabetes mellitus increases the risk of early onset of cardiovascular disease in patients, which poses a major threat to human health. Exploring the impact of type 2 diabetes mellitus on prognosis of patients with dilated cardiomyopathy
WANG Haiyan, HUANG Yuan, GUI Chun
doaj   +1 more source

NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy

Redox Biology, 2020
Dilated cardiomyopathy (DCM) is one of the most common causes of heart failure, and the underlying mechanism remains largely elusive. Here we investigated whether NLRP3 inflammasome-mediated pyroptosis contributes to non-ischemic DCM and dissected the ...
C. Zeng, Fengqi Duan, Jia Hu, B. Luo, Bin Huang, X. Lou, Xiuting Sun, Hongyu Li, Xuanhong Zhang, Shengli Yin, Hongmei Tan   +10 more
semanticscholar   +1 more source

BMAL1 regulates mitochondrial fission and mitophagy through mitochondrial protein BNIP3 and is critical in the development of dilated cardiomyopathy

Protein & Cell, 2020
Dysregulation of circadian rhythms associates with cardiovascular disorders. It is known that deletion of the core circadian gene Bmal1 in mice causes dilated cardiomyopathy.
Ermin Li, Xiuya Li, Jie Huang, Chen Xu, Qianqian Liang, Kehan Ren, Aobing Bai, Chao Lu, R. Qian, N. Sun   +9 more
semanticscholar   +1 more source

Collagen content, but not the ratios of collagen type III/I mRNAs, differs among hypertensive, alcoholic, and idiopathic dilated cardiomyopathy

Brazilian Journal of Medical and Biological Research, 2008
Cardiac interstitial fibrosis may contribute to ventricular dysfunction and the prognosis of patients with dilated cardiomyopathy. The objective of the present study was to determine if total myocardial collagen content and collagen type III/I (III/I ...
H.N. Soufen, V.M.C. Salemi, I.M.S. Aneas, F.J.A. Ramires, A.M.D. Benício, L.A. Benvenuti, J.E. Krieger, C. Mady   +7 more
doaj   +1 more source

Implications of Genetic Testing in Dilated Cardiomyopathy

Circulation Genomic and Precision Medicine, 2020
Supplemental Digital Content is available in the text. Background: Genetic analysis is a first-tier test in dilated cardiomyopathy (DCM). Electrical phenotypes are common in genetic DCM, but their exact contribution to the clinical course and outcome is ...
J. Verdonschot, M. Hazebroek, I. Krapels, M. Henkens, A. Raafs, Ping Wang, J. Merken, G. Claes, E. Vanhoutte, A. van den Wijngaard, S. Heymans, H. Brunner   +11 more
semanticscholar   +1 more source

Anaesthetic Management of a Patient with Dilated Cardiomyopathy for Fracture Femur Surgery-A Case Report [PDF]

Journal of Clinical and Diagnostic Research, 2014
Dilated cardiomyopathy (DCM) is defined as impairment of the ventricular function of the myocardium. The management of a patient with dilated cardiomyopathy, who undergoes a non-cardiac surgery, is always a challenge for an anaesthesiologist, as this ...
Koramutla Pradeep Kumar, Gudaru Jagadesh
doaj   +1 more source

Molecular studies in familial dilated cardiomyopathy – A pilot study

International Journal of Cardiology: Heart & Vasculature, 2022
Aim: To study genetic variants in patients of familial dilated cardiomyopathy. Methodology: Patients with reduced ejection fraction of less than 45% and dilated left ventricle are considered to have dilated cardiomyopathy.
Vyom Mori, J.P.S. Sawhney, I.C. Verma, Ashwani Mehta, Renu Saxena, Rajiv Passey, Arun Mohanty, Bhuwanesh Kandpal, B.S. Vivek, Manish Sharma, Ashish Kumar Jain, Dipak Katare   +11 more
doaj   +1 more source

Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial

The Lancet, 2019
Summary Background Patients with dilated cardiomyopathy whose symptoms and cardiac function have recovered often ask whether their medications can be stopped. The safety of withdrawing treatment in this situation is unknown. Methods We did an open-label,
B. Halliday, R. Wassall, A. Lota, Z. Khalique, J. Gregson, S. Newsome, R. Jackson, T. Rahneva, R. Wage, Gillian Smith, L. Venneri, U. Tayal, D. Auger, W. Midwinter, N. Whiffin, R. Rajani, J. Dungu, A. Pantazis, S. Cook, J. Ware, A. Baksi, D. Pennell, S. Rosen, M. Cowie, J. Cleland, S. Prasad   +25 more
semanticscholar   +1 more source

Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy

Circulation Cardiovascular Imaging, 2020
Supplemental Digital Content is available in the text. Background: Dilated cardiomyopathy is associated with increased risk of major cardiovascular events.
A. Alba, J. Gaztanaga, F. Foroutan, P. Thavendiranathan, M. Merlo, David Alonso-Rodríguez, Victor Vallejo-García, R. Vidal-Pérez, C. Corros-Vicente, M. Barreiro-Pérez, P. Pazos-López, E. Pérez-David, S. Dykstra, J. Flewitt, J. Pérez-Rivera, María Vázquez-Caamaño, S. Katz, G. Sinagra, L. Køber, J. Poole, H. Ross, M. Farkouh, James A. White   +22 more
semanticscholar   +1 more source

Psoriasis as risk factor for non-ischemic dilated cardiomyopathy: a population-based cross-sectional study

BMC Cardiovascular Disorders, 2021
Background Psoriasis is a chronic inflammatory skin condition commonly associated with psoriatic arthritis, malignancy, diabetes, inflammatory bowel disease, and cardiovascular disease.
Abbas Alshami, Nasam Alfraji, Steven Douedi, Swapnil Patel, Mohammad Hossain, Deborah Alpert, Dawn Calderon   +6 more
doaj   +1 more source